Function of von Willebrand factor in children with diarrhea-associated hemolytic-uremic syndrome (D+ HUS)

Seminars in Thrombosis and Hemostasis

Volumn 27, Issue 3, 2001, Pages 287-292

  Sutor, A H ^a   Thomas, K B ^a   Prufer F H A ^a   Grohmann, A ^a   Brandis, M ^a   Zimmerhackl, L B ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Chronic renal failure; Gastroenteritis; Hemolytic uremic syndrome; Idiopathic thrombocytopenic purpura; Von Willebrand factor antigen; Von Willebrand factor collagen binding activity

Indexed keywords

COLLAGEN; VON WILLEBRAND FACTOR;

CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; ENDOTHELIUM LESION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; GASTROENTERITIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFANT; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION;

EID: 0034968198     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15267     Document Type: Conference Paper

References (35)

1. Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes
2. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome
3. Coagulation changes associated with the hemolytic uremic syndrome
4. The hemolytic-uraemic syndrome in childhood
5. The role of coagulation and fibrinolysis in the pathogenesis of diarrhea associated hemolytic uremic syndrome
6. Hemolytic uremic syndromes in childhood
7. Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
8. Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome
9. Von Willebrand factor abnormalities in thrombotic thrombocytopenic purpura and the uremic syndrome
10. Alteration of the von Willebrand factor in children with hemolytic uremic syndrome
11. Triplet structure of human von Willebrand factor
12. Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolytic-uremic syndrome: A prospective study in Germany and Austria
13. Von Willebrand factor: Clinical features of inherited and acquired disorders
14. The management of von Willebrand disease
15. Von Willebrand factor-collagen binding activity is increased in newborns and infants
16. Von Willebrand factor
17. Von Willebrand factor
18. Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura - New insights into underlying biochemical mechanisms
19. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: A tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)
20. Multimeric analysis of von Willebrand factor by molecular sieving electrophoresis in sodium dodecyl sulphate agarose gel
21. Ristocetin - A new tool in the investigation of platelet aggregation
22. Collagen binding assay for von Willebrand factor (VWF:CBA): Detection of von Willebrand's disease (VWD), and discrimination of VWD subtypes, depends on collagen source
23. An ELISA test for the binding of von Willebrand antigen to collagen
24. A simple test for the determination of the von Willebrand factor function: The collagen binding activity
25. Von Willebrand factor - Collagen binding activity. A comparison of methods able to differentiate von Willebrand disease type I and II. Preliminary results
26. Collagen covalently immobilized onto plastic surfaces simplifies measurement of von Willebrand factor-collagen binding activity
27. Enterohemorrhagic Escherichia coli infections: Following transmission routes
28. Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency
29. Soluble circulating cell adhesion molecules in haemolytic uraemic syndrome
30. Plasmatic parameters of coagulation activation in thrombotic microangiopathy
31. Abnormalities of factor VIII related protein multimers in the haemolytic uraemic syndrome
32. Von Willebrand factor and the endothelium
33. The pivotal role of the endothelial cell in the pathogenesis of HUS
34. The role of platelet von Willebrand factor in patients with Von Willebrand disease
35. Von Willebrand factor binding to collagen in patients with end-stage renal disease